CJC-1295 With DAC vs Without DAC Compared

CJC-1295 with DAC vs without DAC: how the two differ in structure, naming and molecular mass, and what identity testing should show for each.

Published 28 October 2026

The distinction in CJC-1295 with DAC vs without DAC is not a minor naming detail. It changes the molecule itself: its structure, its molecular mass and therefore what identity testing should show. Before comparing analytical data or sourcing material, it is worth establishing precisely what the label is intended to describe.

Both names are commonly used in peptide research. They are also used inconsistently by some suppliers. For a laboratory, that makes identity, modification status and batch-specific documentation more useful than broad product descriptions.

What DAC means in CJC-1295#

DAC stands for Drug Affinity Complex. In this context, it refers to a chemical group added to the peptide that is designed to bind serum albumin, a highly abundant protein in serum.

The important point is that DAC is part of the molecular specification. It is not a handling feature, a packaging term or a general statement about quality. A DAC-modified material has a different molecular mass from its non-DAC counterpart, and that difference should be reflected in identity testing.

The albumin-binding design#

Structurally, the DAC version carries an extra lysine residue at the C-terminus bearing a maleimide-based linker. It is this added group, not the peptide sequence, that is designed to bond to albumin, and it is the origin of the differences reported in the literature between the two forms.

That mechanism should not be reduced to a universal prediction. Albumin concentration, matrix composition, species differences, temperature, assay design and the presence of other binding components can all influence observed behaviour. A result from one experimental system should not be assumed to transfer directly to another.

CJC-1295 with DAC vs without DAC: the core differences#

The central comparison is one of molecular architecture. CJC-1295 with DAC contains the albumin-binding modification. Material described as CJC-1295 without DAC does not, so it has a lower molecular mass and should give a different result in identity testing.

Neither form is inherently the correct choice. The appropriate material depends on the experimental question, the model and the analytical endpoints. Treating the two as interchangeable because their names share “CJC-1295” introduces an avoidable source of variation.

Naming is not always consistent#

A further complication is that “CJC-1295 without DAC” is sometimes used as shorthand for related growth hormone-releasing hormone analogue materials. Depending on the source, this may refer to a particular modified sequence, often called modified GRF (1-29), rather than simply “CJC-1295 minus DAC”. Those descriptions may overlap in informal discussion while representing distinct specifications.

For that reason, laboratories should not rely on the product name alone. The stated sequence, terminal modifications, molecular mass and analytical identity data should be reviewed together. If any one of these is absent or unclear, the designation may not be sufficiently specific for controlled research work.

The DAC designation is not a quality marker#

The DAC modification is often the first difference researchers encounter, but it says nothing about material quality. Whether a molecule carries DAC describes its design; it does not establish identity, chemical purity, peptide content, solubility or suitability for a particular assay.

This distinction matters when comparing suppliers. Product pages may place heavy emphasis on the DAC mechanism while offering little evidence that the supplied material matches the claimed structure. A laboratory needs both pieces of information: a clear rationale for the selected molecular form and evidence that the batch being considered has been independently analysed.

The experimental matrix also matters. Behaviour observed in a simplified in-vitro assay may differ from behaviour in serum-containing media. Likewise, a binding-related effect may be muted or altered where albumin is absent, deliberately reduced or replaced. Recording matrix conditions is therefore as relevant to reproducibility as recording the peptide designation.

What to verify before ordering research material#

The most useful checks are specific and batch-led. First, confirm whether the material is explicitly stated to contain DAC or to be without DAC. Then check that the listed molecular mass is compatible with that designation and that the identity method is named.

A certificate of analysis should be read as an analytical record, not as a marketing badge. Consider which test was performed, what the chromatogram or mass data establish, which laboratory issued the document and whether the certificate can be independently verified. If a batch has been submitted for quantification rather than purity determination, that should be stated plainly rather than implied by a blank field or a generic specification.

It is also worth separating analytical purity from peptide content. Chromatographic purity describes the relative signal attributed to components under a stated method. It does not, by itself, establish the total mass of peptide present in a vial, nor does it guarantee performance in a particular experimental system. Those are different questions requiring different measurements and controls.

Whichever supplier is used, the underlying batch record lets a researcher inspect the reported method and result directly, rather than relying on a broad, forward-looking minimum specification. Pioneer Research Peptides is re-checking its own certificates and is not publishing them until that is finished.

Designing comparisons that remain interpretable#

When comparing DAC and non-DAC materials, change one variable at a time where possible. If the aim is to examine the effect of the DAC modification, use clearly defined materials, retain the same analytical framework and document the matrix conditions that may influence albumin binding.

Controls should be selected around the question being asked. For a stability study, the relevant controls may concern time, temperature, matrix composition and recovery through the analytical method. For a receptor-related assay, controls may instead focus on assay baseline, reference material handling and signal specificity. The required design is not identical across research settings.

Storage and handling records also deserve attention. Peptides can be affected by moisture exposure, repeated temperature changes and unnecessary time in solution. A well-documented batch can still yield difficult-to-interpret data if the handling history is incomplete. Recording receipt condition, storage conditions, reconstitution details within the laboratory and sample age helps keep later comparisons meaningful.

Research boundaries and documentation#

CJC-1295 materials supplied for this category are supplied for laboratory research use only. They are not licensed medicines and are not supplied for human or veterinary consumption. These boundaries should remain clear in purchasing records, study documentation and internal material labelling.

For UK laboratories, domestic stockholding and same-day dispatch on orders placed before the stated cut-off can simplify procurement, but shipping speed should not replace document review. The more useful standard is traceability: a specific batch, a readable certificate, a named independent laboratory and a molecular specification that matches the experiment.

What this comparison is not#

Nothing above describes use in people. CJC-1295 in either form is supplied strictly as a research reagent for in-vitro laboratory work; it is not a licensed medicine, it has not been evaluated for human safety or efficacy, and it is not for human or veterinary consumption.

A careful comparison begins with a simple question: does the study require a DAC-modified albumin-binding design, or a material without that modification? Once that is answered, the next task is not to generalise from the product name, but to verify the batch named on your order and its certificate.

Pioneer Research Peptides — UK supplier of research peptides for laboratory use. Ask about batch documentation before you order.

For laboratory research use only — not for human consumption. 18+.